pages · PDF
Brain fog is research-described as a neurobiological event — neuroinflammation, mitochondrial dysfunction in neurons, and impaired BDNF signaling — not willpower. The protocol addresses all three upstream drivers: Semax (intranasal, BDNF + cerebral blood flow within 2–5 days), Selank (GABA-A modulation without sedation), Methylene Blue (Complex IV bypass — pharmaceutical grade ONLY, 0.5–1 mg, hormetic curve). The TBI tier adds physician-administered Cerebrolysin + BPC-157 for structural injury. CRITICAL: Methylene Blue is a MAOI — life-threatening serotonin syndrome risk with any SSRI/SNRI/serotonergic medication. Use Semax + Selank alternative if you take any antidepressant.
Unlock: Cognitive Clarity — Brain Fog, Cognitive Decline & TBI Recovery
Enter your details to get instant access to this free guide.
No spam. We respect your privacy.
“These guides saved me weeks of research. The evidence ratings alone changed how I approach my protocols.”
-- Verified DoseCraft user
Why this matters
If you've been told brain fog is stress, sleep debt, or willpower — the literature describes a different model. Brain fog is a neurobiological event with measurable upstream drivers: neuroinflammation suppressing synaptic transmission, mitochondrial dysfunction reducing the ATP available for cognition, and impaired BDNF signaling failing to maintain neural connections. Research describes three targeted compounds — one that elevates BDNF and cerebral blood flow within days, one that modulates GABA-A without sedation, and one that bypasses mitochondrial bottlenecks at Complex IV — addressing all three failures upstream. A critical note before you read further: one of the three compounds in this protocol (Methylene Blue) is a monoamine oxidase inhibitor. Combining it with any SSRI, SNRI, MAOI, or serotonergic medication can trigger serotonin syndrome — a potentially fatal emergency. If you take any antidepressant, the Semax + Selank alternative is the only path forward in this guide.
What you'll learn
- Why brain fog is a neurobiological event — not willpower deficit — with three measurable upstream drivers
- Why the Methylene Blue + SSRI/SNRI/MAOI combination is a life-threatening emergency (serotonin syndrome) — and the Semax + Selank alternative if you take any antidepressant
- How to triage your own presentation: brain fog (reversible) vs cognitive decline (neuronal loss) vs TBI (structural injury)
- How Semax intranasal bypasses the blood-brain barrier and elevates BDNF + cerebral blood flow within 2–5 days
- Why Selank produces anxiolytic and cognitive-clarity effects via GABA-A modulation without sedation or addiction
- The Methylene Blue hormetic curve: 0.5–1 mg = beneficial · 2–5 mg = diminishing · 10–15 mg+ = pro-oxidant and HARMFUL
- Why pharmaceutical/USP-grade Methylene Blue is non-negotiable — aquarium/industrial grades contain heavy metal contaminants
- Why G6PD screening is mandatory before any Methylene Blue dose (hemolytic anemia risk)
- When the TBI tier applies — Cerebrolysin physician-administered cycles + Semax + BPC-157 for structural recovery
The protocol at a glance
Dose
Brain-fog tier: Semax 200–600 mcg intranasal · Selank 200–400 mcg intranasal · Methylene Blue 0.5–1 mg oral AM (pharmaceutical/USP grade ONLY) · TBI tier: Cerebrolysin 5–10 mL IM/IV physician-administered · Semax 400–600 mcg intranasal · BPC-157 500 mcg SubQ
Frequency
Brain-fog tier: Semax 1–2×/day intranasal · Selank 1–2×/day intranasal · Methylene Blue daily AM with food · TBI tier: Cerebrolysin daily × 10–20 days per cycle · Semax 2×/day intranasal · BPC-157 2×/day SubQ
Cycle
Semax: 30 days on / 10 days off · Selank: 30 days on / 10 days off · Methylene Blue: 8 weeks on / 4 weeks off · Cerebrolysin TBI: daily × 10–20 days, then 2–3 cycles 4 weeks apart · BPC-157 TBI: continuous 8–12 weeks
Timeline
Semax cognitive effects: 2–5 days (BDNF + cerebral blood flow elevate fast) · Selank anxiolytic / clarity: within 15–60 minutes per dose · Methylene Blue mitochondrial support builds over 2–4 weeks · Full brain-fog protocol assessment at 30 days · TBI cognitive improvement often within the first 10-day Cerebrolysin cycle
Cautions
LIFE-THREATENING CONTRAINDICATION — Methylene Blue is a monoamine oxidase inhibitor (MAOI). Combining with ANY SSRI, SNRI, MAOI, tricyclic, or serotonergic medication can trigger serotonin syndrome (hyperthermia >40°C, seizures, muscle rigidity, autonomic instability, cardiovascular collapse) with onset within minutes to hours of co-administration. If you take ANY antidepressant or serotonergic medication, do NOT use Methylene Blue — use the Semax + Selank alternative documented below. Mandatory G6PD deficiency screen before any Methylene Blue use (hemolytic anemia risk). Pharmaceutical/USP-grade Methylene Blue ONLY — aquarium and industrial grades contain heavy metal contaminants (arsenic, lead, mercury, zinc, cadmium) toxic at any dose. The Methylene Blue dose ceiling is 1 mg; above 2 mg/kg the compound flips to pro-oxidant and damages the mitochondria it is meant to protect. Cerebrolysin must be physician-administered — never self-inject IV. Dihexa (cognitive-decline tier) has limited human safety data and a theoretical HGF concern with pre-existing tumors — treat as experimental.
Is this for you?
- Adults with subjective cognitive impairment (brain fog, reduced focus, post-meal cognitive slump, low mental stamina) and no diagnosis of dementia
- Post-viral / long-COVID cognitive symptoms without neuronal-loss imaging findings
- Post-concussion / mild TBI presentations within 6 months of injury (TBI tier — physician-coordinated)
- Age-related cognitive decline with measurable neuronal loss on imaging or neuropsych testing (cognitive-decline tier — physician-coordinated; out of scope for the unsupervised brain-fog protocol)
- Adults willing to coordinate with a physician for G6PD screening before any Methylene Blue use
- Adults NOT taking any SSRI, SNRI, MAOI, tricyclic, or other serotonergic medication (or willing to use the Semax + Selank alternative if they are)
- Anyone currently taking an SSRI, SNRI, MAOI, tricyclic antidepressant, or other serotonergic medication — Methylene Blue is contraindicated (use Semax + Selank alternative only)
- G6PD deficiency (untested or confirmed) — Methylene Blue contraindicated; hemolytic anemia risk
- Active dementia diagnosis (Alzheimer's, vascular, Lewy body) — out of scope; coordinate with neurology
- Active stroke recovery or post-stroke <6 months — physician-only management
- Pregnancy or breastfeeding
- Active malignancy — Dihexa contraindicated (HGF pathway concern); other compounds require oncology sign-off
- Under 21 years of age
The mechanism — why it works
Brain fog is a neurobiological event, not willpower
Standard framing treats brain fog as a lifestyle problem — sleep more, stress less, try harder. The literature describes a different model: brain fog is the subjective experience of three measurable upstream failures. (1) Neuroinflammation — elevated microglial cytokines (IL-6, TNF-α) suppress synaptic transmission and impair long-term potentiation. (2) Mitochondrial dysfunction in neurons — the brain consumes ~20% of total ATP at ~2% of body mass; even modest ATP shortfall reduces cognitive throughput before any structural change is visible. (3) Impaired BDNF signaling — without sufficient brain-derived neurotrophic factor, synapses fail to maintain and prune appropriately. The 'fog' is what these three failures feel like from inside.
LIFE-THREATENING: Methylene Blue + serotonergic medications = serotonin syndrome
This is the single most important safety section in this guide — read it twice. Methylene Blue is a potent monoamine oxidase inhibitor (MAOI). When MAOIs are combined with any drug that elevates synaptic serotonin — SSRIs (fluoxetine/Prozac, sertraline/Zoloft, paroxetine/Paxil, citalopram/Celexa, escitalopram/Lexapro, fluvoxamine/Luvox), SNRIs (venlafaxine/Effexor, duloxetine/Cymbalta, desvenlafaxine/Pristiq, milnacipran), other MAOIs (phenelzine, tranylcypromine, isocarboxazid, selegiline), tricyclics, tramadol, dextromethorphan, MDMA, certain triptans, or St. John's Wort — synaptic serotonin can rise to toxic levels and trigger serotonin syndrome. Presentation includes hyperthermia >40°C (104°F), seizures, muscle rigidity, clonus, autonomic instability, and cardiovascular collapse. Onset is within minutes to hours of co-administration. Mortality without prompt treatment is significant. Washout requirements before any Methylene Blue use: 5 full weeks for fluoxetine (active metabolite half-life 4–16 days); 2 weeks for all other SSRIs/SNRIs; 2–3 weeks for other MAOIs. NEVER discontinue an antidepressant without prescribing-physician guidance — SSRI/SNRI withdrawal syndrome is its own medical risk. If you are taking any of these medications, do not use Methylene Blue. The Semax + Selank pathway below produces meaningful cognitive-clarity effects without MAOI exposure.
Semax — BDNF and cerebral blood flow within days
Semax is a synthetic heptapeptide analogue of ACTH(4–10) developed in Russian neuropeptide research. Intranasal administration bypasses the blood-brain barrier via the olfactory and trigeminal nerve pathways — clinically measurable cerebral effect without systemic exposure. Research describes BDNF elevation and cerebral blood flow increases within 2–5 days of starting the protocol, with downstream effects on focus, mental stamina, and recovery from cognitive fatigue. The intranasal route is critical — oral Semax is degraded before reaching circulation. Dosing: 200–600 mcg intranasal 1–2×/day; 30 days on / 10 days off cycling preserves receptor sensitivity.
Selank — anxiolytic and cognitive clarity without sedation
Selank is a synthetic heptapeptide analogue of the endogenous immunopeptide tuftsin. It modulates GABA-A receptor sensitivity, elevates BDNF, and stabilizes enkephalin signaling — producing anxiolytic effects comparable to benzodiazepines in research-described trials without the sedation, cognitive blunting, dependence, or rebound anxiety. Research describes the anxiety-driven component of brain fog (the 'too anxious to focus' presentation) responding within 15–60 minutes of an intranasal dose. Layered with Semax, the combination addresses both the BDNF-axis cognitive substrate (Semax) and the anxiety-driven cognitive interference (Selank) in parallel.
Methylene Blue — mitochondrial bypass at Complex IV (hormetic curve)
Methylene Blue acts as an alternative electron carrier at cytochrome c oxidase (Complex IV of the electron transport chain), bypassing mitochondrial bottlenecks where the natural ETC components are damaged or operating below capacity. The mechanism is dose-dependent and hormetic — a non-monotonic curve where the same molecule is therapeutic at low dose, neutral at mid dose, and harmful at high dose. The research describes the curve as: 0.5–1 mg = antioxidant electron shuttle + ETC bypass + ATP boost (the therapeutic window); 2–5 mg = diminishing returns approaching the pro-oxidant threshold; 10–15 mg+ = pro-oxidant — Methylene Blue itself generates the reactive oxygen species it is meant to reduce, damages mitochondrial membranes, and depletes the ATP it is meant to produce. This is not 'more is better' territory. The therapeutic dose is 0.5–1 mg ORAL with food in the morning. Pharmaceutical/USP-grade ONLY — aquarium and industrial grades contain heavy metal contaminants (arsenic, lead, mercury, zinc, cadmium) that are toxic at any dose. G6PD deficiency screen mandatory before first dose (hemolytic anemia risk).
BPC-157 — blood-brain barrier crossing and neuroprotection
BPC-157 crosses the blood-brain barrier and produces neuroprotective effects via VEGF-pathway angiogenesis, dopamine-system stabilization, and inflammation modulation. In the TBI tier it addresses the structural-injury inflammatory cascade alongside Cerebrolysin's direct neurotrophic input. In the brain-fog tier BPC-157 is optional — included when there is overlapping gut-driven inflammation (the gut-brain axis) feeding the neuroinflammatory baseline.
Cerebrolysin — physician-administered neurotrophic mixture (TBI tier)
Cerebrolysin is a porcine-brain-derived neurotrophic peptide mixture containing BDNF-mimetic, NGF-mimetic, and CNTF-mimetic fragments. It is approved in 35+ countries for stroke recovery, TBI, and dementia adjunctive treatment. Administration is intramuscular or slow intravenous — physician-administered only, never self-injected IV. The TBI tier protocol is 5–10 mL daily for 10–20 consecutive days per cycle, followed by 2–3 additional cycles 4 weeks apart. Research describes cognitive improvement often within the first 10-day cycle. Layered with Semax (intranasal, BDNF) and BPC-157 (SubQ, neuroprotection + angiogenesis), the TBI tier addresses structural recovery, BDNF substrate, and inflammatory load simultaneously.
Triage: brain fog vs cognitive decline vs TBI
Use this presentation map before selecting a tier. (1) BRAIN FOG — subjective cognitive impairment without imaging or neuropsych findings of neuronal loss. Reversible. This is the brain-fog tier: Semax + Selank ± Methylene Blue. (2) AGE-RELATED COGNITIVE DECLINE — measurable neuronal loss on MRI volumetrics or formal neuropsych testing (MMSE, MoCA decline). Requires the cognitive-decline tier described in ch.33b: Dihexa (HGF-modulating synaptic-repair compound) + Semax + Cerebrolysin. This tier is physician-coordinated, has limited human safety data on Dihexa, and is out of scope for unsupervised use. (3) TBI / POST-CONCUSSION — structural injury with documented mechanism (impact, blast, whiplash) within 6 months. Requires the TBI tier: physician-administered Cerebrolysin cycles + Semax 2×/day intranasal + BPC-157 SubQ 2×/day for 8–12 weeks. If you cannot triage with certainty, coordinate with a neurologist before starting any of the three tiers.
What you'll feel — week by week
Days 1–7
Semax cognitive effects often begin within 2–5 days — increased focus, faster mental recovery, reduced post-meal slump. Selank produces dose-by-dose anxiolytic effect within 15–60 minutes; the anxious-rumination component of brain fog typically eases in this window. Methylene Blue effects are subtle in week 1; mitochondrial support builds gradually.
Weeks 2–4
BDNF-axis effects compound. Methylene Blue's mitochondrial bypass produces measurable cognitive endurance gains by week 2–4. Users typically describe reduced afternoon cognitive crash, improved word recall, and steadier focus across the workday. This is the window where the cumulative effect becomes obvious vs the early dose-by-dose effect.
Day 30
Brain-fog protocol assessment endpoint. Compare subjective cognitive scores (or a formal cognitive self-rating) to baseline. Begin the 10-day off-cycle for Semax + Selank to preserve receptor sensitivity. Methylene Blue continues through week 8 before its 4-week off-cycle.
TBI tier: cycles 1–3
Cerebrolysin cognitive improvement is often described within the first 10-day cycle — improved attention, reduced cognitive fatigue, faster word retrieval. Subsequent cycles (4 weeks apart) build cumulative effect. Semax 2×/day and BPC-157 SubQ 2×/day run continuously through 8–12 weeks. Formal neurocognitive reassessment at week 12.
What could go wrong
Common (no action)
- Mild nasal irritation with Semax/Selank — rotate nostrils; adjust spray angle
- Transient mild headache in week 1 of Methylene Blue — usually resolves with food + hydration
- Blue-green urine discoloration with Methylene Blue — harmless, expected
- Mild fatigue or vivid dreams in early Selank use — anxiolytic adaptation; resolves
Watch + adjust
- Any new medication added during the protocol — check the SSRI/SNRI/serotonergic list before continuing Methylene Blue
- Cognitive symptoms worsening rather than improving by week 4 — re-triage between brain fog vs cognitive decline vs TBI; coordinate with a neurologist
- Methylene Blue doses creeping above 1 mg — STOP and return to 0.5 mg; pro-oxidant threshold approaches at 2–5 mg
- G6PD status uncertain — pause Methylene Blue and screen before resuming
Stop + seek care
- ANY symptoms of serotonin syndrome — hyperthermia, severe muscle rigidity, clonus, agitation, confusion, rapid heart rate, severe sweating: STOP Methylene Blue immediately and seek EMERGENCY care
- Hemolytic anemia signs (dark urine, jaundice, severe fatigue, shortness of breath) — STOP Methylene Blue, emergency care
- Anaphylactic or severe allergic reaction at any injection or intranasal site — emergency care
- New focal neurologic symptoms (weakness, slurred speech, vision changes) — emergency care; the protocol is not designed to mask stroke presentations
Bloodwork — what to track
Pre-protocol mandatory: G6PD activity (mandatory before any Methylene Blue dose) · Medication review (any SSRI/SNRI/MAOI/tricyclic/serotonergic — Methylene Blue contraindicated) · hs-CRP (neuroinflammation baseline) · TSH + free T4 (rule out thyroid-driven cognitive presentation) · Fasting insulin + HbA1c (insulin-resistance contribution to neuroinflammation) · Vitamin B12 + folate + homocysteine · 25-OH vitamin D · CBC with differential. TBI tier additionally: baseline neurocognitive assessment (MoCA or formal neuropsych battery) · imaging per neurology (CT/MRI as indicated). Reassess hs-CRP and cognitive self-rating at week 4 and week 12.
Frequently asked
I'm on an SSRI for depression — can I still do this protocol?
Not the Methylene Blue arm — it is absolutely contraindicated. Methylene Blue is a monoamine oxidase inhibitor; combining it with any SSRI, SNRI, MAOI, tricyclic, or other serotonergic medication can trigger serotonin syndrome, a potentially fatal emergency (hyperthermia >40°C, seizures, muscle rigidity, cardiovascular collapse, onset within minutes to hours). Use the Semax + Selank alternative: Semax 400–600 mcg intranasal 1–2×/day and Selank 200–400 mcg intranasal 1–2×/day, both on 30 days on / 10 days off cycles. The research describes meaningful cognitive-clarity effects from this two-compound pathway without MAOI exposure. Never discontinue your antidepressant without your prescribing physician — SSRI/SNRI withdrawal is its own clinical risk, and fluoxetine specifically requires a 5-week washout before any future Methylene Blue use.
Why is 0.5–1 mg the Methylene Blue dose when biohacking forums say 10–15 mg?
The forum dose is wrong and dangerous. Methylene Blue follows a hormetic dose-response curve: at 0.5–1 mg it functions as an antioxidant electron shuttle and Complex IV bypass — beneficial. At 2–5 mg returns diminish and the pro-oxidant threshold approaches. At 10–15 mg+ Methylene Blue flips to a pro-oxidant: it generates the reactive oxygen species it is meant to reduce, damages mitochondrial membranes, and depletes the ATP it is meant to produce. The difference between therapeutic and harmful is 10–30×. The protocol dose is 0.5–1 mg oral with food in the morning, pharmaceutical/USP grade only.
Is brain fog actually reversible, or am I just describing aging?
Triage matters here. Brain fog — subjective cognitive impairment without imaging or neuropsych findings of neuronal loss — is research-described as a neurobiological event driven by reversible upstream failures (neuroinflammation, mitochondrial dysfunction, impaired BDNF signaling). Address those substrates and the literature describes meaningful cognitive recovery. Age-related cognitive decline with measurable neuronal loss on volumetric MRI or neuropsych testing is a different category — it requires the Dihexa + Cerebrolysin tier described in the canonical chapter, is physician-coordinated, and is out of scope for unsupervised use. If you have any objective decline finding, coordinate with a neurologist before starting any tier.
Why intranasal Semax and Selank rather than injectable?
Intranasal administration bypasses the blood-brain barrier via the olfactory and trigeminal nerve pathways — the compound reaches the CNS in clinically meaningful concentration without systemic exposure. Oral Semax and Selank are degraded before reaching circulation. Subcutaneous injection produces measurable plasma levels but achieves lower CNS concentrations than intranasal at the same dose. For the cognitive indication, intranasal is the documented route.
Can I buy Methylene Blue from an aquarium supply store?
No — and this is not a hedge. Aquarium-grade and industrial-grade Methylene Blue contain heavy metal contaminants (arsenic, lead, mercury, zinc, cadmium) that are toxic at any oral dose. The cost difference vs pharmaceutical/USP grade is minimal; the safety difference is absolute. Pharmaceutical/USP grade is certified to ≥99% purity with documented absence of heavy metals. There is no scenario where aquarium-grade is the right choice for human use.
I had a concussion 3 months ago — is the brain-fog protocol the right tier?
No — that is the TBI tier. Recent structural brain injury requires Cerebrolysin (physician-administered IM/IV, 5–10 mL daily × 10–20 days, then 2–3 cycles 4 weeks apart) plus Semax 400–600 mcg intranasal 2×/day plus BPC-157 500 mcg SubQ 2×/day for 8–12 weeks. The TBI tier is physician-coordinated. Self-administering only the brain-fog tier after a recent concussion under-treats the structural component and misses the documented Cerebrolysin recovery window.
What does G6PD screening actually look like, and is it expensive?
G6PD activity is a single blood test ordered by your physician — it measures glucose-6-phosphate dehydrogenase enzyme activity in red blood cells. Cost is typically modest and it is widely available. G6PD deficiency is the most common enzyme deficiency globally (more prevalent in men, and in people of Mediterranean, African, Middle Eastern, and Southeast Asian ancestry). If deficient, Methylene Blue can trigger hemolytic anemia — red blood cell destruction — a potentially life-threatening reaction. The test is mandatory before any Methylene Blue dose; do not skip it.
Cited research
Verified Vendors
Where to get these compounds
MyOasis Labs carries intranasal Semax and Selank in their catalog — the route documented in the research for cognitive indications. Methylene Blue must be pharmaceutical/USP grade (not aquarium/industrial). BPC-157 is injectable (SubQ) for the TBI tier. Cerebrolysin is physician-administered and sourced through clinical channels — coordinate with a neurologist. Source the research peptides from the verified vendor below; confirm HPLC + mass-spec testing.
Peptide Partners
Practitioner-tier research peptides
HPLC + Mass-Spec verified · Free replacement on failed third-party tests
MyOasis Labs
Widest catalog — injectables, oral caps, blends
Third-party lab tested · Every batch
Hydro Research Peptides
Research-grade peptides — 20% off your order
Research peptides · newest addition to the verified roster
Affiliate disclosure: DoseCraft earns a small commission on orders made through these vendor links — at no extra cost to you. We only partner with vendors that pass our internal vendor-rubric audit.
Ready for the full experience?
DoseCraft gives you AI-powered protocol building, 90+ compound library, dose tracking, and evidence-rated stacks from leading practitioners.
Get Started — Try DoseCraft NowNot medical advice — educational only. These guides are for informational and research purposes only. Always consult a licensed healthcare professional before starting any peptide protocol.